Timing is the protocol, not a refinement of it
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market
Other considerations include a small increased risk of lower limb amputation and bone fractures observed primarily with canagliflozin in certain trials
2021 Jun:167:37-43
Allison Gross is the founder of The 4Q Method and is a New York based dietitian.
doi: 10.1056/NEJMra1615439 Summary Keywords diabetic peripheral neuropathy, glucagon-like peptide-1 receptor agonists, neuroprotection, inflammation, oxidative stress Citation Liu C, Wu T and Ren N (2024) Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy